Dysplazja włóknisto-mięśniowa – Zapobieganie i profilaktyka

Dysplazja włóknisto-mięśniowa
Zapobieganie i profilaktyka

Dysplazja włóknisto-mięśniowa (FMD) to nieateromatyczna, niezapalna choroba naczyń średniego kalibru, charakteryzująca się nieprawidłowym rozwojem komórek ściany tętnic, co prowadzi do zwężeń, tętniaków lub rozwarstwień. Etiologia FMD pozostaje niejasna, z podejrzeniem komponentu genetycznego. Profilaktyka opiera się głównie na modyfikacji stylu życia: zaprzestaniu palenia tytoniu, regularnej aktywności fizycznej (np. chodzenie, pływanie), diecie ubogiej w sód i nasycone tłuszcze oraz kontroli masy ciała. Leczenie farmakologiczne obejmuje stosowanie leków przeciwpłytkowych (np. ASA w małych dawkach stosowany u 72,9% pacjentów z Rejestru USA), przeciwzakrzepowych, inhibitorów ACE i/lub antagonistów receptora angiotensyny II (ARB, np. olmesartan) szczególnie u chorych z zajęciem tętnic nerkowych, a także blokerów kanału wapniowego w profilaktyce niedokrwienia mózgu. Nadciśnienie tętnicze, często związane z FMD tętnic nerkowych, wymaga monitorowania i leczenia zgodnego z wytycznymi JNC, a w przypadkach opornych lub z utratą funkcji nerki rozważa się rewaskularyzację lub nefrektomię.

Profilaktyka Dysplazji włóknisto-mięśniowej

Modyfikacja stylu życia
Farmakologiczne metody profilaktyki
Kontrola ciśnienia tętniczego
Kompleksowa diagnostyka i monitorowanie
Poradnictwo genetyczne

Zapobieganie powikłaniom
Postępy w badaniach nad dysplazją włóknisto-mięśniową

Kolejne rozdziały

Profilaktyka Dysplazji włóknisto-mięśniowej

Dysplazja włóknisto-mięśniowa (FMD) to nieateromatyczna, niezapalna choroba naczyniowa dotycząca głównie tętnic średniej wielkości, prowadząca do nieprawidłowego rozwoju komórek w ścianach tętnic, co może powodować zwężenie, wybrzuszenie lub rozwarstwienie naczyń.¹ Ze względu na fakt, że naukowcy nie określili jeszcze dokładnych przyczyn dysplazji włóknisto-mięśniowej, nie istnieją strategie zapobiegania rozwojowi tej choroby.²³ Dodatkowo podejrzewa się, że schorzenie to może mieć komponent genetyczny.⁴

Modyfikacja stylu życia

Mimo że dysplazji włóknisto-mięśniowej nie można całkowicie zapobiec, zaleca się wdrożenie zmian w stylu życia, które mogą zmniejszyć ryzyko powikłań naczyniowych i korzystnie wpłynąć na przebieg choroby:⁵⁶

Zaprzestanie palenia tytoniu – używanie tytoniu może pogorszyć przebieg dysplazji włóknisto-mięśniowej i innych chorób naczyniowych, dlatego zaprzestanie palenia jest kluczowym środkiem profilaktycznym⁷⁸⁹
Regularna aktywność fizyczna – ćwiczenia o niskiej intensywności, takie jak chodzenie i pływanie, mogą poprawić zdrowie układu sercowo-naczyniowego i pomóc utrzymać prawidłowe ciśnienie krwi¹⁰
Zdrowa dieta – zrównoważona dieta korzystna dla serca, uboga w sód i nasycone tłuszcze, może pomóc kontrolować ciśnienie krwi i sprzyjać ogólnemu dobremu samopoczuciu¹¹
Kontrola wagi – utrzymanie prawidłowej masy ciała stanowi istotny element profilaktyki chorób naczyniowych¹²

Farmakologiczne metody profilaktyki

Leczenie farmakologiczne jest ważnym elementem profilaktyki powikłań u pacjentów z FMD. Obejmuje ono różne grupy leków w zależności od lokalizacji zmian i objawów:¹³

Leki przeciwpłytkowe – zgodnie z danymi z Rejestru USA, 72,9% zarejestrowanych pacjentów było leczonych lekami przeciwpłytkowymi. Jest to standardowe podejście w praktyce klinicznej w zapobieganiu zdarzeniom zakrzepowo-zatorowym. Najczęściej stosuje się kwas acetylosalicylowy w małej dawce.¹⁴¹⁵¹⁶
Leki przeciwzakrzepowe – mogą być stosowane jako profilaktyka przeciwko powikłaniom, szczególnie w przypadkach, gdy FMD powoduje minimalne zmiany zwężające.¹⁷¹⁸
Inhibitory ACE i/lub ARB (antagoniści receptora angiotensyny II) – zalecane są wszystkim pacjentom z FMD w obrębie tętnic nerkowych.¹⁹ Obserwacje sugerują potencjalną skuteczność antagonistów receptora AT1 (ARB, np. olmesartan) w modyfikowaniu naturalnego przebiegu niemiażdżycowych chorób tętnic, takich jak FMD.²⁰
Blokery kanału wapniowego – przepisywane w celu zapobiegania nawracającym epizodom niedokrwienia mózgu.²¹

Kontrola ciśnienia tętniczego

Nadciśnienie tętnicze jest częstym powikłaniem FMD, szczególnie gdy dotknięte są tętnice nerkowe. Regularne monitorowanie i przepisane leki mogą pomóc zapobiec uszkodzeniu ważnych narządów i zmniejszyć ryzyko chorób serca i udaru mózgu.²² Leczenie farmakologiczne nadciśnienia w FMD powinno być zgodne z wytycznymi Joint National Committee dotyczącymi zapobiegania, wykrywania, oceny i leczenia wysokiego ciśnienia krwi.²³

W przypadku młodych pacjentów z nadciśnieniem opornym na leczenie farmakologiczne, nietolerujących leków przeciwnadciśnieniowych lub u których doszło do utraty objętości nerki z powodu nefropatii niedokrwiennej, rewaskularyzacja może być leczeniem z wyboru, a celem jest wyleczenie choroby.²⁴ W skrajnych przypadkach nadciśnienia, po niepowodzeniu pierwotnej operacji lub gdy nerka nie jest zdolna do prawidłowego funkcjonowania, można wykonać nefrektomię, co może skutkować całkowitym wyleczeniem.²⁵

Kompleksowa diagnostyka i monitorowanie

Ze względu na zmienność lokalizacji i objawów FMD oraz wysoką częstość występowania tętniaków i rozwarstwień, wszyscy pacjenci powinni przejść kompleksowe jednorazowe badanie przesiewowe od głowy do miednicy podczas diagnostyki FMD.²⁶ Regularne kontrole lekarskie są niezbędne do monitorowania progresji choroby i wczesnego wykrywania potencjalnych powikłań.²⁷

Poradnictwo genetyczne

Osoby z rodzinną historią dysplazji włóknisto-mięśniowej mogą odnieść korzyści z poradnictwa genetycznego, które może pomóc ocenić ich własny poziom ryzyka i określić, czy którykolwiek z krewnych powinien rozważyć wczesne badania przesiewowe lub monitoring.²⁸

Zapobieganie powikłaniom

Zapobieganie powikłaniom FMD może obejmować zarządzanie znanymi lub podejrzewanymi czynnikami ryzyka udaru mózgu, takimi jak nadciśnienie tętnicze, migotanie przedsionków, palenie tytoniu i stosowanie pigułek antykoncepcyjnych.²⁹ Pacjenci powinni być szczególnie wyczuleni na nowe objawy, w tym zmiany widzenia, mowy oraz niewyjaśnione zmiany w funkcjonowaniu kończyn górnych lub dolnych, i niezwłocznie zgłaszać je lekarzowi.³⁰

Interwencje naczyniowe (np. angioplastyka lub wewnątrznaczyniowe bądź chirurgiczne leczenie tętniaka) są określane głównie na podstawie objawów, przy czym angioplastyka tętnicy nerkowej w leczeniu nadciśnienia jest najczęstszym zabiegiem związanym z FMD.³¹

Postępy w badaniach nad dysplazją włóknisto-mięśniową

Towarzystwo Dysplazji Włóknisto-Mięśniowej Ameryki (Fibromuscular Dysplasia Society of America) współpracuje z Uniwersytetem Michigan nad Międzynarodowym Rejestrem Pacjentów, a Narodowy Instytut Zdrowia prowadzi badania nad FMD w celu zidentyfikowania jej mechanizmów biologicznych i molekularnych.³² Wraz z postępem badań istnieje nadzieja na jeszcze skuteczniejsze metody leczenia i głębsze zrozumienie tej choroby.³³

Chociaż nie ma możliwości całkowitego wyleczenia dysplazji włóknisto-mięśniowej, postępowanie koncentruje się na dokładnej ocenie i nadzorze, modyfikacji stylu życia oraz leczeniu objawów.³⁴ Wczesna diagnoza i szybkie leczenie, szczególnie w przypadku dysplazji włóknisto-mięśniowej tętnic nerkowych jako przyczyny nadciśnienia naczyniowo-nerkowego, mogą prowadzić do szybkiego i całkowitego wyzdrowienia.³⁵

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

Materiały źródłowe

#1 Fibromuscular Dysplasia: A Comprehensive Insight – Longmore Clinic
https://longmoreclinic.org/fibromuscular-dysplasia-a-comprehensive-insight/
Fibromuscular Dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease that predominantly affects the medium-sized arteries. It leads to abnormal cell development in the arterial walls, which can cause the vessels to narrow, bulge, or even dissect. […] While FMD isn’t preventable due to its inherent nature, certain measures might reduce the risk: Refraining from tobacco products. Keeping blood pressure in check. Regular health screenings if there’s a family history. […] Understanding Fibromuscular Dysplasia is crucial for timely diagnosis and management. As research progresses, there’s hope for even more effective treatments and a deeper understanding of this condition.
#2 Fibromuscular Dysplasia: Causes, Symptoms and Treatment
https://my.clevelandclinic.org/health/diseases/17001-fibromuscular-dysplasia-fmd
Because scientists dont understand the causes of FMD, there are no strategies to prevent it. […] Treatment focuses on relieving symptoms and preventing complications.
#3 Fibromuscular dysplasia (patient information) – wikidoc
https://www.wikidoc.org/index.php/Fibromuscular_dysplasia_(patient_information)
It cannot be prevented. smoking cessation may reduce your chance of developing it.
#4 Fibromuscular Dysplasia | Tampa General Hospital
https://www.tgh.org/institutes-and-services/conditions/fibromuscular-disease
Fibromuscular disease cannot be completely prevented, mainly because its exact cause remains unknown. Additionally, scientists believe the condition may have a genetic component. Even so, certain steps can be taken to manage it and help reduce the risk of complications. These include: […] Exercising regularly. Low-impact physical activities, such as walking and swimming, can improve cardiovascular health and help keep blood pressure in check. […] Maintaining healthy eating habits. A balanced, heart-healthy diet low in sodium and saturated fats can help control blood pressure and promote overall wellness. […] Managing hypertension. High blood pressure is a common complication of FMD, particularly when the renal arteries are affected. Regular monitoring and prescribed medications can help prevent damage to vital organs and reduce the risk of heart disease and stroke.
#5 Fibromuscular Dysplasia Treatment & Management: Approach Considerations, Medical Care, Surgical Care
https://emedicine.medscape.com/article/1161248-treatment
Lifestyle changes that minimize the risk of vascular disease should be stressed. These changes include quitting smoking, weight control, doing exercise, and eating a healthy diet.
#6 Fibromuscular Dysplasia | Tampa General Hospital
https://www.tgh.org/institutes-and-services/conditions/fibromuscular-disease
Fibromuscular disease cannot be completely prevented, mainly because its exact cause remains unknown. Additionally, scientists believe the condition may have a genetic component. Even so, certain steps can be taken to manage it and help reduce the risk of complications. These include: […] Exercising regularly. Low-impact physical activities, such as walking and swimming, can improve cardiovascular health and help keep blood pressure in check. […] Maintaining healthy eating habits. A balanced, heart-healthy diet low in sodium and saturated fats can help control blood pressure and promote overall wellness. […] Managing hypertension. High blood pressure is a common complication of FMD, particularly when the renal arteries are affected. Regular monitoring and prescribed medications can help prevent damage to vital organs and reduce the risk of heart disease and stroke.
#7 Fibromuscular Dysplasia | Tampa General Hospital
https://www.tgh.org/institutes-and-services/conditions/fibromuscular-disease
Quitting smoking. Tobacco use can worsen fibromuscular dysplasia and other vascular conditions; therefore, smoking cessation is a key preventive measure. […] Seeking genetic counseling. Individuals with a family history of fibromuscular disease may benefit from genetic counseling, which can help assess their own risk level and determine whether any relatives should consider early screening or monitoring.
#8 Fibromuscular dysplasia (patient information) – wikidoc
https://www.wikidoc.org/index.php/Fibromuscular_dysplasia_(patient_information)
It cannot be prevented. smoking cessation may reduce your chance of developing it.
#9 Fibromuscular dysplasia – Humanitas.net
https://www.humanitas.net/diseases/fibromuscular-dysplasia/
In general, fibromuscular dysplasia is not preventable. However, quitting smoking may reduce the risk of developing the disease.
#10 Fibromuscular Dysplasia | Tampa General Hospital
https://www.tgh.org/institutes-and-services/conditions/fibromuscular-disease
Fibromuscular disease cannot be completely prevented, mainly because its exact cause remains unknown. Additionally, scientists believe the condition may have a genetic component. Even so, certain steps can be taken to manage it and help reduce the risk of complications. These include: […] Exercising regularly. Low-impact physical activities, such as walking and swimming, can improve cardiovascular health and help keep blood pressure in check. […] Maintaining healthy eating habits. A balanced, heart-healthy diet low in sodium and saturated fats can help control blood pressure and promote overall wellness. […] Managing hypertension. High blood pressure is a common complication of FMD, particularly when the renal arteries are affected. Regular monitoring and prescribed medications can help prevent damage to vital organs and reduce the risk of heart disease and stroke.
#11 Fibromuscular Dysplasia | Tampa General Hospital
https://www.tgh.org/institutes-and-services/conditions/fibromuscular-disease
Fibromuscular disease cannot be completely prevented, mainly because its exact cause remains unknown. Additionally, scientists believe the condition may have a genetic component. Even so, certain steps can be taken to manage it and help reduce the risk of complications. These include: […] Exercising regularly. Low-impact physical activities, such as walking and swimming, can improve cardiovascular health and help keep blood pressure in check. […] Maintaining healthy eating habits. A balanced, heart-healthy diet low in sodium and saturated fats can help control blood pressure and promote overall wellness. […] Managing hypertension. High blood pressure is a common complication of FMD, particularly when the renal arteries are affected. Regular monitoring and prescribed medications can help prevent damage to vital organs and reduce the risk of heart disease and stroke.
#12 Fibromuscular Dysplasia Treatment & Management: Approach Considerations, Medical Care, Surgical Care
https://emedicine.medscape.com/article/1161248-treatment
Lifestyle changes that minimize the risk of vascular disease should be stressed. These changes include quitting smoking, weight control, doing exercise, and eating a healthy diet.
#13 Fibromuscular dysplasia: Advances in understanding and management | Cleveland Clinic Journal of Medicine
https://www.ccjm.org/content/83/11_suppl_2/s45
There is no cure for FMD. Management focuses on thorough evaluation and surveillance, lifestyle modification, and treatment of symptoms. Vascular procedures, such as angioplasty or treatment of aneurysms, are required for some patients. […] Because of the variability in location and manifestations of FMD and the high prevalence of aneurysm and dissection, all patients should undergo comprehensive one-time head-to-pelvis screening during the workup for FMD. […] The medical regimen for patients with FMD varies based on disease location and symptoms, though there are no definitive treatment guidelines because of limited data. A study from the US Registry found that 72.9% of registrants were treated with antiplatelet medications, and this is a standard approach in our clinical practice for prevention of thromboembolic events. […] The need for vascular intervention (eg, angioplasty or endovascular or surgical aneurysm treatment) is determined primarily by symptoms, with renal artery angioplasty for hypertension the most common FMD-related procedure.
#14 Fibromuscular dysplasia: Advances in understanding and management | Cleveland Clinic Journal of Medicine
https://www.ccjm.org/content/83/11_suppl_2/s45
There is no cure for FMD. Management focuses on thorough evaluation and surveillance, lifestyle modification, and treatment of symptoms. Vascular procedures, such as angioplasty or treatment of aneurysms, are required for some patients. […] Because of the variability in location and manifestations of FMD and the high prevalence of aneurysm and dissection, all patients should undergo comprehensive one-time head-to-pelvis screening during the workup for FMD. […] The medical regimen for patients with FMD varies based on disease location and symptoms, though there are no definitive treatment guidelines because of limited data. A study from the US Registry found that 72.9% of registrants were treated with antiplatelet medications, and this is a standard approach in our clinical practice for prevention of thromboembolic events. […] The need for vascular intervention (eg, angioplasty or endovascular or surgical aneurysm treatment) is determined primarily by symptoms, with renal artery angioplasty for hypertension the most common FMD-related procedure.
#15 Fibromuscular dysplasia – Knowledge @ AMBOSS
https://www.amboss.com/us/knowledge/fibromuscular-dysplasia/
All patients with renal FMD should be treated with ACE inhibitors and/or ARBs, while those with carotid artery involvement should be placed on stroke prophylaxis (low-dose aspirin therapy). […] Antiplatelet drugs (e.g., aspirin) for stroke prophylaxis is recommended for all patients.
#16 FIBROMUSCULAR DYSPLASIA (Chapter 65) – Uncommon Causes of Stroke
https://www.cambridge.org/core/books/uncommon-causes-of-stroke/fibromuscular-dysplasia/8C4E1F6E383EC9C2DFE2BC3F271E2D77
Fibromuscular dysplasia (FMD) is a nonatheromatous multifocal condition known to affect almost any systemic or brain-supplying artery, but this condition has special predilection for specific arterial sites. […] Antiplatelet aggregating agents and calcium-channel blockers have been prescribed to prevent recurrent episodes of brain ischemia.
#17 Does treatment with olmesartan improve arterial stenoses due to fibromuscular dysplasia? | Hypertension Research
https://www.nature.com/articles/hr2009126
No data are available in literature about the remission of arterial stenoses during treatment of FMD. […] When FMD produces minimal stenotic lesions, it may be managed conservatively by antiplatelet or anticoagulant therapy as prophylaxis against complications. […] Although it is arduous to accept that AT1-blockers may have a pleyotropic effect that modifies the natural history of FMD, it is difficult as well to not attribute the modifications of arteries observed on imaging to medical treatment. […] The Fibromuscular Dysplasia Society of America is working together with the University of Michigan on an International Patient Registry, and the National Institute of Health is conducting a research on FMD to individualize its biological and molecular mechanisms. […] This suggests a potential efficacy of AT1-blockers in modifying the natural history of non-atherosclerotic arterial diseases such as FMD.
#18 Fibromuscular Dysplasia: Symptoms, Treatment, and Life Expectancy
https://www.healthline.com/health/fibromuscular-dysplasia
Theres no cure for FMD, but you can manage it. Treatments can help you to manage your symptoms and prevent complications of the disease. […] You may also need to take blood thinners, such as aspirin, to prevent blood clots. These make it easier for blood to pass through narrowed arteries. […] Work with your doctor to find the best way to manage your symptoms, and make sure to tell them if you notice any new symptoms, including: vision changes, speech changes, unexplained changes in your arms or legs.
#19 Fibromuscular dysplasia – Knowledge @ AMBOSS
https://www.amboss.com/us/knowledge/fibromuscular-dysplasia/
All patients with renal FMD should be treated with ACE inhibitors and/or ARBs, while those with carotid artery involvement should be placed on stroke prophylaxis (low-dose aspirin therapy). […] Antiplatelet drugs (e.g., aspirin) for stroke prophylaxis is recommended for all patients.
#20 Does treatment with olmesartan improve arterial stenoses due to fibromuscular dysplasia? | Hypertension Research
https://www.nature.com/articles/hr2009126
No data are available in literature about the remission of arterial stenoses during treatment of FMD. […] When FMD produces minimal stenotic lesions, it may be managed conservatively by antiplatelet or anticoagulant therapy as prophylaxis against complications. […] Although it is arduous to accept that AT1-blockers may have a pleyotropic effect that modifies the natural history of FMD, it is difficult as well to not attribute the modifications of arteries observed on imaging to medical treatment. […] The Fibromuscular Dysplasia Society of America is working together with the University of Michigan on an International Patient Registry, and the National Institute of Health is conducting a research on FMD to individualize its biological and molecular mechanisms. […] This suggests a potential efficacy of AT1-blockers in modifying the natural history of non-atherosclerotic arterial diseases such as FMD.
#21 FIBROMUSCULAR DYSPLASIA (Chapter 65) – Uncommon Causes of Stroke
https://www.cambridge.org/core/books/uncommon-causes-of-stroke/fibromuscular-dysplasia/8C4E1F6E383EC9C2DFE2BC3F271E2D77
Fibromuscular dysplasia (FMD) is a nonatheromatous multifocal condition known to affect almost any systemic or brain-supplying artery, but this condition has special predilection for specific arterial sites. […] Antiplatelet aggregating agents and calcium-channel blockers have been prescribed to prevent recurrent episodes of brain ischemia.
#22 Fibromuscular Dysplasia | Tampa General Hospital
https://www.tgh.org/institutes-and-services/conditions/fibromuscular-disease
Fibromuscular disease cannot be completely prevented, mainly because its exact cause remains unknown. Additionally, scientists believe the condition may have a genetic component. Even so, certain steps can be taken to manage it and help reduce the risk of complications. These include: […] Exercising regularly. Low-impact physical activities, such as walking and swimming, can improve cardiovascular health and help keep blood pressure in check. […] Maintaining healthy eating habits. A balanced, heart-healthy diet low in sodium and saturated fats can help control blood pressure and promote overall wellness. […] Managing hypertension. High blood pressure is a common complication of FMD, particularly when the renal arteries are affected. Regular monitoring and prescribed medications can help prevent damage to vital organs and reduce the risk of heart disease and stroke.
#23 A case of treatable hypertension: fibromuscular dysplasia of renal arteries | BMC Research Notes | Full Text
https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-015-1835-z
Fibromuscular dysplasia causing renal artery stenosis, though a rare cause of renovascular hypertension, is essential to be considered in young hypertensives, even in the absence of family history of hypertension. […] A high index of suspicion is necessary in early diagnosis and prompt treatment, which can result in rapid and complete recovery. […] Pharmacological treatment of hypertension in FMD should follow the guidelines of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. […] Revascularization is the choice of treatment in patients with young hypertension refractory to pharmacological therapy, those who are intolerant to antihypertensive, those who have lost renal volume due to ischaemic nephropathy, and the goal is to cure the disease. […] When the criteria for revascularization are not met, or in extreme hypertension, or following failed primary surgery, or when a kidney is non-viable nephrectomy can be performed as in this case, resulting in complete cure.
#24 A case of treatable hypertension: fibromuscular dysplasia of renal arteries | BMC Research Notes | Full Text
https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-015-1835-z
Fibromuscular dysplasia causing renal artery stenosis, though a rare cause of renovascular hypertension, is essential to be considered in young hypertensives, even in the absence of family history of hypertension. […] A high index of suspicion is necessary in early diagnosis and prompt treatment, which can result in rapid and complete recovery. […] Pharmacological treatment of hypertension in FMD should follow the guidelines of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. […] Revascularization is the choice of treatment in patients with young hypertension refractory to pharmacological therapy, those who are intolerant to antihypertensive, those who have lost renal volume due to ischaemic nephropathy, and the goal is to cure the disease. […] When the criteria for revascularization are not met, or in extreme hypertension, or following failed primary surgery, or when a kidney is non-viable nephrectomy can be performed as in this case, resulting in complete cure.
#25 A case of treatable hypertension: fibromuscular dysplasia of renal arteries | BMC Research Notes | Full Text
https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-015-1835-z
Fibromuscular dysplasia causing renal artery stenosis, though a rare cause of renovascular hypertension, is essential to be considered in young hypertensives, even in the absence of family history of hypertension. […] A high index of suspicion is necessary in early diagnosis and prompt treatment, which can result in rapid and complete recovery. […] Pharmacological treatment of hypertension in FMD should follow the guidelines of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. […] Revascularization is the choice of treatment in patients with young hypertension refractory to pharmacological therapy, those who are intolerant to antihypertensive, those who have lost renal volume due to ischaemic nephropathy, and the goal is to cure the disease. […] When the criteria for revascularization are not met, or in extreme hypertension, or following failed primary surgery, or when a kidney is non-viable nephrectomy can be performed as in this case, resulting in complete cure.
#26 Fibromuscular dysplasia: Advances in understanding and management | Cleveland Clinic Journal of Medicine
https://www.ccjm.org/content/83/11_suppl_2/s45
There is no cure for FMD. Management focuses on thorough evaluation and surveillance, lifestyle modification, and treatment of symptoms. Vascular procedures, such as angioplasty or treatment of aneurysms, are required for some patients. […] Because of the variability in location and manifestations of FMD and the high prevalence of aneurysm and dissection, all patients should undergo comprehensive one-time head-to-pelvis screening during the workup for FMD. […] The medical regimen for patients with FMD varies based on disease location and symptoms, though there are no definitive treatment guidelines because of limited data. A study from the US Registry found that 72.9% of registrants were treated with antiplatelet medications, and this is a standard approach in our clinical practice for prevention of thromboembolic events. […] The need for vascular intervention (eg, angioplasty or endovascular or surgical aneurysm treatment) is determined primarily by symptoms, with renal artery angioplasty for hypertension the most common FMD-related procedure.
#27 Fibromuscular Dysplasia: Symptoms, Treatment, and Life Expectancy
https://www.healthline.com/health/fibromuscular-dysplasia
Theres no cure for FMD, but you can manage it. Treatments can help you to manage your symptoms and prevent complications of the disease. […] You may also need to take blood thinners, such as aspirin, to prevent blood clots. These make it easier for blood to pass through narrowed arteries. […] Work with your doctor to find the best way to manage your symptoms, and make sure to tell them if you notice any new symptoms, including: vision changes, speech changes, unexplained changes in your arms or legs.
#28 Fibromuscular Dysplasia | Tampa General Hospital
https://www.tgh.org/institutes-and-services/conditions/fibromuscular-disease
Quitting smoking. Tobacco use can worsen fibromuscular dysplasia and other vascular conditions; therefore, smoking cessation is a key preventive measure. […] Seeking genetic counseling. Individuals with a family history of fibromuscular disease may benefit from genetic counseling, which can help assess their own risk level and determine whether any relatives should consider early screening or monitoring.
#29 Fibromuscular dysplasia | MedLink Neurology
https://www.medlink.com/articles/fibromuscular-dysplasia
No specific methods of preventing fibromuscular dysplasia are known. Prevention of complications may involve the management of known or suspected risk factors for stroke (eg, hypertension, atrial fibrillation, smoking, and use of birth control pills).
#30 Fibromuscular Dysplasia: Symptoms, Treatment, and Life Expectancy
https://www.healthline.com/health/fibromuscular-dysplasia
Theres no cure for FMD, but you can manage it. Treatments can help you to manage your symptoms and prevent complications of the disease. […] You may also need to take blood thinners, such as aspirin, to prevent blood clots. These make it easier for blood to pass through narrowed arteries. […] Work with your doctor to find the best way to manage your symptoms, and make sure to tell them if you notice any new symptoms, including: vision changes, speech changes, unexplained changes in your arms or legs.
#31 Fibromuscular dysplasia: Advances in understanding and management | Cleveland Clinic Journal of Medicine
https://www.ccjm.org/content/83/11_suppl_2/s45
There is no cure for FMD. Management focuses on thorough evaluation and surveillance, lifestyle modification, and treatment of symptoms. Vascular procedures, such as angioplasty or treatment of aneurysms, are required for some patients. […] Because of the variability in location and manifestations of FMD and the high prevalence of aneurysm and dissection, all patients should undergo comprehensive one-time head-to-pelvis screening during the workup for FMD. […] The medical regimen for patients with FMD varies based on disease location and symptoms, though there are no definitive treatment guidelines because of limited data. A study from the US Registry found that 72.9% of registrants were treated with antiplatelet medications, and this is a standard approach in our clinical practice for prevention of thromboembolic events. […] The need for vascular intervention (eg, angioplasty or endovascular or surgical aneurysm treatment) is determined primarily by symptoms, with renal artery angioplasty for hypertension the most common FMD-related procedure.
#32 Does treatment with olmesartan improve arterial stenoses due to fibromuscular dysplasia? | Hypertension Research
https://www.nature.com/articles/hr2009126
No data are available in literature about the remission of arterial stenoses during treatment of FMD. […] When FMD produces minimal stenotic lesions, it may be managed conservatively by antiplatelet or anticoagulant therapy as prophylaxis against complications. […] Although it is arduous to accept that AT1-blockers may have a pleyotropic effect that modifies the natural history of FMD, it is difficult as well to not attribute the modifications of arteries observed on imaging to medical treatment. […] The Fibromuscular Dysplasia Society of America is working together with the University of Michigan on an International Patient Registry, and the National Institute of Health is conducting a research on FMD to individualize its biological and molecular mechanisms. […] This suggests a potential efficacy of AT1-blockers in modifying the natural history of non-atherosclerotic arterial diseases such as FMD.
#33 Fibromuscular Dysplasia: A Comprehensive Insight – Longmore Clinic
https://longmoreclinic.org/fibromuscular-dysplasia-a-comprehensive-insight/
Fibromuscular Dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease that predominantly affects the medium-sized arteries. It leads to abnormal cell development in the arterial walls, which can cause the vessels to narrow, bulge, or even dissect. […] While FMD isn’t preventable due to its inherent nature, certain measures might reduce the risk: Refraining from tobacco products. Keeping blood pressure in check. Regular health screenings if there’s a family history. […] Understanding Fibromuscular Dysplasia is crucial for timely diagnosis and management. As research progresses, there’s hope for even more effective treatments and a deeper understanding of this condition.
#34 Fibromuscular dysplasia: Advances in understanding and management | Cleveland Clinic Journal of Medicine
https://www.ccjm.org/content/83/11_suppl_2/s45
There is no cure for FMD. Management focuses on thorough evaluation and surveillance, lifestyle modification, and treatment of symptoms. Vascular procedures, such as angioplasty or treatment of aneurysms, are required for some patients. […] Because of the variability in location and manifestations of FMD and the high prevalence of aneurysm and dissection, all patients should undergo comprehensive one-time head-to-pelvis screening during the workup for FMD. […] The medical regimen for patients with FMD varies based on disease location and symptoms, though there are no definitive treatment guidelines because of limited data. A study from the US Registry found that 72.9% of registrants were treated with antiplatelet medications, and this is a standard approach in our clinical practice for prevention of thromboembolic events. […] The need for vascular intervention (eg, angioplasty or endovascular or surgical aneurysm treatment) is determined primarily by symptoms, with renal artery angioplasty for hypertension the most common FMD-related procedure.
#35 A case of treatable hypertension: fibromuscular dysplasia of renal arteries | BMC Research Notes | Full Text
https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-015-1835-z
Fibromuscular dysplasia causing renal artery stenosis, though a rare cause of renovascular hypertension, is essential to be considered in young hypertensives, even in the absence of family history of hypertension. […] A high index of suspicion is necessary in early diagnosis and prompt treatment, which can result in rapid and complete recovery. […] Pharmacological treatment of hypertension in FMD should follow the guidelines of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. […] Revascularization is the choice of treatment in patients with young hypertension refractory to pharmacological therapy, those who are intolerant to antihypertensive, those who have lost renal volume due to ischaemic nephropathy, and the goal is to cure the disease. […] When the criteria for revascularization are not met, or in extreme hypertension, or following failed primary surgery, or when a kidney is non-viable nephrectomy can be performed as in this case, resulting in complete cure.